A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome

BACKGROUND: Ample evidence indicates the efficacy of serotonin type 3 (5-HT(3)) receptor antagonists in the treatment of patients with diarrhea-predominant irritable bowel syndrome (IBS-D). Mirtazapine is an atypical antidepressant with a well-known 5-HT(3) receptor antagonist property. This study,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biopsychosoc Med
Main Authors: Khalilian, Alireza, Ahmadimoghaddam, Davoud, Saki, Shiva, Mohammadi, Younes, Mehrpooya, Maryam
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7860197/
https://ncbi.nlm.nih.gov/pubmed/33536043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13030-021-00205-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados